NL-OMON48676
Recruiting
N/A
Determining prognostic immune markers in patients with ovarian cancer * a prospective explorative cohort study. - IMPrOVE
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- eids Universitair Medisch Centrum
- Enrollment
- 300
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\* Patients with (suspicion of) primary or recurrent EOC with an indication for
- •surgery, chemotherapy and/or immunotherapy.
- •\* Age \*18 years.
- •\* WHO performance status 0\-2\.
- •\* Accessible for treatment and follow\-up.
- •\* Written informed consent.
Exclusion Criteria
- •\* Other active malignancy in past 5 years prior to entry into the study, except
- •for treated non\-melanoma skin cancer.
- •\* Any known severe infection like HIV, hepatitis A, B and C.
- •\* Receiving immune suppressive treatment.
- •\* Medical or psychological condition which in the opinion of the investigator
- •would not permit the patient to complete the study or sign meaningful informed
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
Investigation of biomarkers to predict immune-related adverse events in patients with non-small cell lung canceron-small cell lung cancerJPRN-UMIN000047162Kobe University114
Recruiting
N/A
Detection of markers for immune pathophysiology and analysis of their prognostic value in patients with chronic thrombocytopenia without an increase in the number of bone marrow megakaryocytes: a prospective observation study.Pancytopenia, thrombocytopeniaJPRN-UMIN000002729Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science.50
Recruiting
N/A
Prospective immune biomarker identification trial for renal cell carcinoma treatment.Renal cell carcinomaJPRN-UMIN000047119Keio University, school of medicine100
Unknown
N/A
Immunological Markers Predictive of Response and Toxicity to Checkpoint Inhibitors in Non-small Cell Lung CancerLung CancerNCT04918836University Hospital, Brest150
Completed
N/A
Can Immunohistochemical markers be a prognostic factors in malignant pleural mesothelioma patients?JPRN-UMIN000015825Hyogo Prefectural Amagasaki Hospital350